Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold
VEGFR-2 als neues antiangiogenes Target
VEGFR-2 (KDR/Flk-1).
Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023)
Design and synthesis of new inhibitors of VEGFR-2.